
Capridob Capsules
October 6, 2026
Grankast 180
October 6, 2026Livgran Infusion
What is Livgran Infusion
Livgran Infusion is a prescription hepatoprotective medication containing L-Ornithine L-Aspartate (5 gm per 10 ml). Formulated as a concentrated solution for intravenous drip infusion, Livgran is primarily used to treat severe liver diseases, hepatic encephalopathy, and high toxic ammonia levels in the blood.
Key Ingredients & Their Role
Livgran Infusion contains the following active component:
-
L-Ornithine L-Aspartate (5 gm / 10 ml):
-
Ammonia Detoxification: Combines two key amino acids (ornithine and aspartate) that stimulate the urea cycle and glutamine synthesis, effectively converting toxic ammonia into non-toxic urea for excretion.
-
Hepatic Cell Protection: Promotes cellular energy production and supports liver tissue regeneration in damaged or failing livers.
-
Benefits & What It Helps With
Using Livgran Infusion can help with:
-
Management of Hepatic Encephalopathy: Reduces blood ammonia levels to alleviate brain dysfunction, confusion, and altered consciousness caused by severe liver failure.
-
Support in Chronic Liver Diseases: Protects liver tissue in conditions such as liver cirrhosis, chronic hepatitis, and severe fatty liver disease.
-
Rapid Ammonia Clearance: Provides fast-acting intravenous detoxification for hospitalized patients experiencing acute hyperammonemia.
Who Should Use Livgran Infusion
This prescription medication is generally indicated for:
-
Hospitalized patients diagnosed with Hepatic Encephalopathy or elevated blood ammonia levels.
-
Individuals with advanced liver cirrhosis or severe chronic liver damage needing acute medical intervention.
Important: Livgran Infusion is a potent prescription drug (marked Rx) and must be administered strictly in a clinical setting under medical supervision.
How to Use & Dosage Advice
-
Administration Route: For I.V. Slow Drip Infusion Only. The concentrate must be diluted in an appropriate infusion solution (e.g., normal saline or dextrose solution) prior to administration.
-
Dosage & Rate: The exact dose, dilution ratio, and infusion speed are determined strictly by the treating gastroenterologist, hepatologist, or critical care physician based on the patient’s condition.
-
Hospital Setting: Must be given by a trained healthcare professional; do not attempt to self-administer.
Precautions & When to Avoid
-
Avoid using if you have severe renal insufficiency or kidney failure (e.g., serum creatinine levels significantly above normal).
-
Contraindicated in patients with known hypersensitivity to L-Ornithine L-Aspartate or any constituents.
-
Infusion rate must be kept slow to avoid nausea, vomiting, or local vascular irritation.
-
Pregnant or breastfeeding women should consult a specialist prior to treatment.
Storage & Handling
-
Store in a cool, dry place protected from direct light, heat, and moisture.
-
Do not freeze.
-
Keep out of reach of children.
-
Packaging: 1 x 10 ml ampoule packaging (Infusion concentrate for slow I.V. drip).
-
Always check the solution for clarity and verify the expiry date prior to administration.







